Amylyx Pharmaceuticals Inc Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
2019
381M
1,612.94%
25M
355M
317M
188M
128M
39M
0M
54M
5M
49M
-124.84%
342M
16M
40M
1M
39M
22M
7,700.00%
3M
19M
221M
127M
93M
-201M
4M
-198M
1M
-198M
125.74%
224M
4M
-201M
0M
-201M
0M
-56.15%
0M
0M
83M
39M
44M
-83M
0M
-88M
0M
-88M
96.00%
83M
0M
-83M
0M
-83M
1M
-54.42%
25M
-24M
39M
15M
25M
-39M
2M
-42M
0M
-45M
202.63%
39M
-2M
-39M
0M
-39M
1M
-
12M
-10M
14M
3M
12M
-14M
1M
-14M
0M
-15M
202.63%
14M
-1M
-13M
0M
-14M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
4Q2020
108M
395.54%
9M
99M
97M
52M
45M
2M
0M
6M
2M
5M
-111.08%
107M
4M
2M
0M
2M
103M
29,666.09%
5M
97M
79M
49M
30M
19M
0M
22M
2M
21M
-138.87%
84M
4M
19M
0M
19M
98M
-
6M
93M
72M
43M
29M
20M
0M
24M
2M
22M
-140.83%
78M
4M
20M
0M
20M
71M
-
5M
66M
68M
44M
24M
-2M
3M
1M
0M
2M
-103.29%
73M
4M
-2M
0M
-2M
22M
-
3M
19M
64M
56M
23M
-45M
3M
-42M
1M
-43M
50.66%
66M
3M
-45M
0M
-45M
0M
21.05%
0M
0M
55M
30M
25M
-55M
1M
-54M
0M
-54M
132.29%
55M
1M
-55M
0M
-55M
0M
-
0M
0M
54M
30M
24M
-54M
0M
-54M
0M
-54M
146.63%
54M
0M
-54M
0M
-54M
0M
-
0M
0M
48M
26M
21M
-48M
0M
-48M
0M
-48M
229.46%
48M
0M
-48M
0M
-48M
0M
-
0M
0M
28M
15M
13M
-28M
0M
-28M
0M
-28M
229.89%
28M
0M
-28M
0M
-28M
0M
-
0M
0M
23M
10M
13M
-23M
0M
-23M
0M
-23M
229.89%
23M
0M
-23M
0M
-23M
0M
-
0M
0M
19M
8M
11M
-19M
0M
-22M
0M
-22M
229.89%
19M
0M
-19M
0M
-19M
0M
-
0M
0M
13M
6M
7M
-13M
0M
-15M
0M
-15M
229.89%
13M
0M
-13M
0M
-13M
0M
-
0M
0M
9M
4M
5M
-9M
0M
-9M
0M
-9M
229.89%
9M
0M
-9M
0M
-9M